Literature DB >> 20166435

Kinetics of pyrimethamine in young and adult rats on a standard diet and on a low-protein diet.

J B Mouankie1, W Senczuk, E Florek.   

Abstract

A pharmacokinetic study of pyrimethamine was carried out in 4- (103-115 g) and 12-week-old (260-280 g) white male Wistar rats fed a standard diet containing 24% protein, and a low-protein diet containing 8% protein. After intragastric administration of the drug in a single dose of 40 mg/kg body weight, the concentrations of pyrimethamine in the blood were determined at different time points from 15 min to 20 hours post-dose. On the basis of the results obtained, a number of parameters characterizing the course of absorption and elimination of the drug from the blood were calculated. The majority of parameters were dependent on both age and type of diet. The greatest bioavailability was observed in the 4-week-old rats: for the animals fed the low-protein diet, the area under the concentration-time curve (AUC) amounted to 593.0 and for those on the standard diet the AUC was 503.1. In the older rats, this parameter was 339.3 and 228.1 respectively. The k(e) values were lower in the younger rats (i.e. 0.0121 h(-1) and 0.0135 h(-1)) than in the older animals (i.e. 0.0164 h(-1) and 0.0193 h(-1) respectively). The elimination half-life (t1/2) was higher in the 4-week-old rats (i.e. 57.1 h; 8% protein, and 51.2 h; 24% protein) than in the 12-week-old animals (i.e. 42.4 h; 8% protein, and 36.0 h; 24% protein).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20166435     DOI: 10.1007/BF03191170

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  4 in total

1.  Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS.

Authors:  L M Weiss; C Harris; M Berger; H B Tanowitz; M Wittner
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

2.  Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.

Authors:  E Weidekamm; D E Schwartz; U C Dubach; B Weber
Journal:  Chemotherapy       Date:  1987       Impact factor: 2.544

3.  Salivary elimination of pyrimethamine.

Authors:  R A Ahmad; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

4.  [Contribution to the determination of four antimalarial molecules (chloroquine, quinine, pyrimethamine, sulfadoxime) mixed in biological fluids. I. Spectrophotometry UV (author's transl)].

Authors:  M Bonini; F Mokofio; S Argilas
Journal:  Toxicol Eur Res       Date:  1981-05
  4 in total
  1 in total

1.  Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.

Authors:  Iftekhar Mahmood; Anna Cheng; Edward Brauer; Rita Humeniuk
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.